XML 67 R46.htm IDEA: XBRL DOCUMENT v3.8.0.1
Quarterly Operating Results (unaudited) (Tables)
12 Months Ended
Dec. 31, 2017
Quarterly Financial Data [Abstract]  
Quarterly Operating Results
2017 (a)
First
Quarter
 
Second
Quarter
 
Third
Quarter
 
Fourth
Quarter
 
Total
Year
 
(b)
 
(c)
 
(d)
 
(e)
 
 
Net revenues
$
1,899

 
$
1,943

 
$
1,931

 
$
1,936

 
$
7,709

Gross profit
734

 
773

 
741

 
742

 
2,990

 
 
 
 
 
 
 
 
 
 
Net income
175

 
207

 
175

 
267

 
824

Less: Net income attributable to noncontrolling interests
11

 
14

 
14

 
13

 
52

Net income attributable to Quest Diagnostics
$
164

 
$
193

 
$
161

 
$
254

 
$
772

 
 
 
 
 
 
 
 
 
 
Earnings per share attributable to Quest Diagnostics' stockholders:
 
 
 
 
 
 
 
 
 
Basic
$
1.19

 
$
1.40

 
$
1.18

 
$
1.86

 
$
5.63

Diluted
$
1.16

 
$
1.37

 
$
1.15

 
$
1.82

 
$
5.50


2016 (a)
First
Quarter
 
Second
Quarter
 
Third
Quarter
 
Fourth
Quarter
 
Total
Year
 
(f)
 
(g)
 
(h)
 
(i)
 
 
Net revenues
$
1,863

 
$
1,906

 
$
1,885

 
$
1,861

 
$
7,515

Gross profit
719

 
751

 
728

 
701

 
2,899

 
 
 
 
 
 
 
 
 
 
Net income
115

 
209

 
205

 
167

 
696

Less: Net income attributable to noncontrolling interests
12

 
14

 
13

 
12

 
51

Net income attributable to Quest Diagnostics
$
103

 
$
195

 
$
192

 
$
155

 
$
645

 
 
 
 
 
 
 
 
 
 
Earnings per share attributable to Quest Diagnostics' stockholders:
 
 
 
 
 
 
 
 
 
Basic
$
0.72

 
$
1.38

 
$
1.37

 
$
1.11

 
$
4.58

Diluted
$
0.71

 
$
1.37

 
$
1.34

 
$
1.09

 
$
4.51


(a)
In May 2016, the Company completed the sale of Focus Diagnostics (see Note 6).

(b)
Included pre-tax charges of $18 million, primarily associated with systems conversions and integration incurred in connection with further restructuring and integrating the Company ($10 million in cost of services and $8 million in selling, general and administrative expenses); and excess tax benefits associated with stock-based compensation arrangements of $16 million recorded in income tax expense.

(c)
Included pre-tax charges of $23 million, primarily associated with systems conversions and integration incurred in connection with further restructuring and integrating the Company ($9 million in cost of services, $13 million in selling, general and administrative expenses, and $1 million in equity in earnings of equity method investees, net of taxes); pre-tax gain of $7 million related to the sale of an interest in an equity method investment (recorded in other income (expense), net); $2 million in costs incurred related to certain legal matters (recorded in selling, general and administrative expenses); and excess tax benefits associated with stock-based compensation arrangements of $13 million recorded in income tax expense.

(d)
Included pre-tax charges of $23 million, primarily associated with systems conversions and integration incurred in connection with further restructuring and integrating the Company ($12 million in cost of services and $11 million in selling, general and administrative expenses); pre-tax charges of $9 million primarily associated with non-cash asset impairment charges and incremental costs incurred as a result of hurricanes ($3 million in cost of services, $1 million in selling, general and administrative expenses, and $5 million in other income (expense), net); and excess tax benefits associated with stock-based compensation arrangements of $7 million recorded in income tax expense.

(e)
Included pre-tax charges of $42 million, primarily associated with systems conversions, integration and workforce reductions incurred in connection with further restructuring and integrating the Company ($14 million in cost of services and $28 million in selling, general and administrative expenses); pre-tax charges of $6 million, primarily related to non-cash asset impairment charges and incremental costs incurred as a result of the hurricanes ($2 million in cost of services and $4 million in selling, general and administrative expenses); a provisional estimated income tax benefit of $106 million associated with the TCJA, including a deferred income tax benefit of $115 million primarily due to the remeasurement of net deferred tax liabilities and reserves at the new combined federal and state tax rate, partially offset by $9 million of current tax expense primarily due to the mandatory repatriation toll charge on undistributed foreign earnings and profits; and excess tax benefits associated with stock-based compensation arrangements of $1 million recorded in income tax expense.

(f)
Included pre-tax charges of $21 million, primarily associated with systems conversions and integration incurred in connection with further restructuring and integrating the Company ($7 million in cost of services, $12 million in selling, general and administrative expenses and $2 million in equity in earnings of equity method investees, net of taxes); pre-tax charges of $1 million, representing non-cash asset impairment charges recorded in other operating expense (income), net; pre-tax charges of $2 million, primarily representing costs incurred related to certain legal matters recorded in selling, general and administrative expenses; pre-tax charges of $48 million on retirement of debt associated with the March 2016 cash tender offer recorded in other income (expense), net (see Note 13); pre-tax charges of $1 million representing non-cash asset impairment charges associated with an investment recorded in other income (expense), net; and excess tax benefits associated with stock-based compensation arrangements of $2 million recorded in income tax expense.

(g)
Included a pre-tax gain of $118 million associated with the sale of Focus Diagnostics; pre-tax charges of $19 million, primarily associated with systems conversions and integration incurred in connection with further restructuring and integrating the Company ($10 million in cost of services, $8 million in selling, general and administrative expenses and $1 million in equity in earnings of equity method investees, net of taxes); pre-tax charges of $1 million, primarily representing costs incurred related to certain legal matters recorded in selling, general and administrative expenses; pre-tax charges of $6 million representing non-cash asset impairment charges associated with certain investments recorded in other income (expense), net; and excess tax benefits associated with stock-based compensation arrangements of $2 million recorded in income tax expense.

(h)
Included pre-tax charges of $18 million, primarily associated with systems conversions and integration incurred in connection with further restructuring and integrating the Company ($8 million in cost of services and $10 million in selling, general and administrative expenses); pre-tax gain of $21 million, principally a result of a gain on escrow recovery associated with an acquisition recorded in other operating expense (income), net; and excess tax benefits associated with stock-based compensation arrangements of $3 million recorded in income tax expense.

(i)
Included pre-tax charges of $24 million, primarily associated with systems conversions and integration incurred in connection with further restructuring and integrating the Company ($15 million in cost of services, $7 million in selling, general and administrative expenses, $1 million in other operating expense (income), net and $1 million in equity in earnings of equity method investees, net of taxes); pre-tax charges of $6 million representing non-cash asset impairment charges recorded in other operating expense (income), net; and excess tax benefits associated with stock-based compensation arrangements of $2 million recorded in income tax expense.